Claret Asset Management’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $32K | Buy |
|
|||||
|
2022
Q3 | $48K | Hold |
|
|||||
|
2022
Q2 | $83K | Hold |
|
|||||
|
2022
Q1 | $240K | Hold |
|
|||||
|
2021
Q4 | $246K | Buy |
|
|||||
|
2021
Q3 | $287K | Buy |
|
|||||
|
2021
Q2 | $378K | Hold |
|
|||||
|
2021
Q1 | $402K | Hold |
|
|||||
|
2020
Q4 | $444K | Buy |
|
|||||
|
2020
Q3 | $460K | Hold |
|
|||||
|
2020
Q2 | $301K | Sell |
|
|||||
|
2020
Q1 | $317K | Sell |
|
|||||
|
2019
Q4 | $456K | Hold |
|
|||||
|
2019
Q3 | $529K | Buy |
|
|||||
|
2019
Q2 | $400K | Sell |
|
|||||
|
2019
Q1 | $561K | Hold |
|
|||||
|
2018
Q4 | $375K | Buy |
|
|||||
|
2018
Q3 | $420K | Hold |
|
|||||
|
2018
Q2 | $405K | Hold |
|
|||||
|
2018
Q1 | $246K | Buy |
|
|||||
|
2017
Q4 | $219K | Buy |
|